Rosetta Genomics Ltd (ROSG)
0.43 unch (unch) 05/21/18 [NASDAQ]
N/A x N/A N/A x N/A
Realtime by (Cboe BZX)
N/A x N/A N/A x N/A
Realtime - - (-) -
for Mon, May 21st, 2018
Results
download Want to compare other data? Select Fields| Symbol | ROSG | REVB | SCNI | ||
| Company | Rosetta Genomics Ltd | Revelation Biosciences Inc | Scinai Immunotherapeutics Ltd ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 0.43 | 2.97 | 2.52 | ||
| High | 0.44 | 3.05 | 2.72 | ||
| Low | 0.42 | 2.85 | 2.52 | ||
| Last | 0.43 | 3.05 | 2.64 | ||
| Change | unch | +0.08 | +0.09 | ||
| % Change | unch | +2.77% | +3.47% | ||
| Volume | 169,500 | 39,800 | 118,600 | ||
| 20-Day Average Volume | 81,460 | 150,745 | 25,905 | ||
| Previous Close | 0.43 | 2.97 | 2.55 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 0.42 | 3.03 | 2.33 | ||
| 20-Day Raw Stochastic | 60.69% | 48.46% | 67.74% | ||
| 20-Day Relative Strength | 53.02% | 46.44% | 49.01% | ||
| Weighted Alpha | -65.38 | -89.04 | -48.95 | ||
| Today's Opinion | N/A | 80% Sell | 88% Sell | ||
| Previous Opinion | N/A | 96% Sell | 88% Sell | ||
| Last Month's Opinion | N/A | 100% Sell | 88% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -2.27% since 05/14/18 | +6.83% since 04/23/25 | +9.02% since 04/23/25 | ||
| Low | 0.42 on 05/21/18 | 2.76 on 04/24/25 | 2.22 on 04/24/25 | ||
| High | 0.44 on 05/21/18 | 3.11 on 04/29/25 | 2.72 on 04/30/25 | ||
| 1-Month | |||||
| %Chg | +14.67% since 04/20/18 | +12.96% since 03/28/25 | -5.77% since 03/28/25 | ||
| Low | 0.32 on 04/23/18 | 2.41 on 04/02/25 | 1.90 on 04/15/25 | ||
| High | 0.50 on 04/26/18 | 3.73 on 04/08/25 | 2.99 on 04/04/25 | ||
| 3-Month | |||||
| %Chg | +7.50% since 02/21/18 | -20.16% since 01/30/25 | -25.05% since 01/30/25 | ||
| Low | 0.23 on 02/23/18 | 2.36 on 03/17/25 | 1.90 on 04/15/25 | ||
| High | 0.50 on 04/26/18 | 4.60 on 02/04/25 | 3.99 on 02/07/25 | ||
| 6-Month | |||||
| %Chg | -41.89% since 11/21/17 | -77.70% since 10/30/24 | -25.89% since 10/30/24 | ||
| Low | 0.23 on 02/23/18 | 2.36 on 03/17/25 | 1.90 on 04/15/25 | ||
| High | 0.83 on 11/22/17 | 20.16 on 01/02/25 | 3.99 on 02/07/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 2,550 | 2,687 | 2,381 | ||
| Shares Outstanding, K | 5,930 | 905 | 934 | ||
| Annual Sales | 9,230,000 | 0 | 0 | ||
| Annual Net Income | -16,230,000 | -15,040,000 | -6,500,000 | ||
| Last Quarter Sales | N/A | 0 | 170,000 | ||
| Last Quarter Net Income | N/A | -1,730,000 | 10,460,000 | ||
| 60-Month Beta | 0.49 | 0.23 | 2.68 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | -4.98 on 03/06/25 | 8.40 on 11/22/24 | ||
| Latest Earnings Date | 04/04/18 | 05/09/25 | 05/21/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||